Free Extracellular miRNA Functionally Targets Cells by Transfecting Exosomes from Their Companion Cells.
Lymph node and spleen cells of mice doubly immunized by epicutaneous and intravenous hapten application produce a suppressive component that inhibits the action of the effector T cells that mediate contact sensitivity reactions. We recently re-investigated this phenomenon in an immunological system. CD8+ T lymphocyte-derived exosomes transferred suppressive miR-150 to the effector T cells antigen-specifically due to exosome surface coat of antibody light chains made by B1a lymphocytes. Extracellular RNA (exRNA) is protected from plasma RNases by carriage in exosomes or by chaperones. Exosome transfer of functional RNA to target cells is well described, whereas the mechanism of transfer of exRNA free of exosomes remains unclear. In the current study we describe extracellular miR-150, extracted from exosomes, yet still able to mediate antigen-specific suppression. We have determined that this was due to miR-150 association with antibody-coated exosomes produced by B1a cell companions of the effector T cells, which resulted in antigen-specific suppression of their function. Thus functional cell targeting by free exRNA can proceed by transfecting companion cell exosomes that then transfer RNA cargo to the acceptor cells. This contrasts with the classical view on release of RNA-containing exosomes from the multivesicular bodies for subsequent intercellular targeting. This new alternate pathway for transfer of exRNA between cells has distinct biological and immunological significance, and since most human blood exRNA is not in exosomes may be relevant to evaluation and treatment of diseases.
Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America; Department of Immunology, Jagiellonian University Medical College, Krakow, Poland.
Krzysztof
K
Bryniarski
Department of Immunology, Jagiellonian University Medical College, Krakow, Poland.
Wlodzimierz
W
Ptak
Department of Immunology, Jagiellonian University Medical College, Krakow, Poland.
Emilia
E
Martin
Department of Immunology, Jagiellonian University Medical College, Krakow, Poland.
Katarzyna
K
Nazimek
Department of Medical Biology, Jagiellonian University Medical College, Krakow, Poland.
Marian
M
Szczepanik
Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
Marek
M
Sanak
Section of Allergy and Clinical Immunology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Philip W
PW
Askenase
D000818:Animals; D000906:Antibodies / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D002460:Cell Line; D055354:Exosomes / Q000235:genetics* / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation; D008810:Mice, Inbred C57BL; D035683:MicroRNAs / Q000235:genetics* / Q000276:immunology* / Q000302:isolation & purification; D051196:Toll-Like Receptor 3 / Q000276:immunology; D014162:Transfection
D000906:Antibodies; D035683:MicroRNAs; C529101:Mirn150 microRNA, mouse; C519703:TLR3 protein, mouse; D051196:Toll-Like Receptor 3